Strategic fit & opportunity
Clarify why Mexico matters, where the opportunity sits, which assumptions must be true and what success would mean for the broader portfolio.
MEXICO MARKET ENTRY · HEALTHCARE GROWTH · STRATEGY & ACTIVATION
Enter Mexico with clarity.
Grow with local advantage.
Operator-led market entry and growth strategy for healthcare companies evaluating, launching or scaling in Mexico.
01 / THE ENTRY QUESTION
A compelling market does not automatically become a compelling business.
Winning in Mexico requires more than a market report. It requires explicit choices about where to play, how value will be recognized, which route to market fits the opportunity and what the organization must be ready to execute.
02 / THE ENTRY DECISIONS
Six decisions that turn market potential into an executable entry thesis.
We connect external opportunity with the access, commercial and organizational choices required to capture it.
Priority segments & portfolio
Select the indications, categories, customer segments and opportunity spaces where the company can create distinctive value.
Access & value pathway
Decode public, institutional and private routes; stakeholder value; evidence; affordability; reimbursement and adoption barriers.
Entry model & partnering
Compare direct entry, distributor, licensing, co-commercialization and alliance models against control, speed, economics and capability requirements.
Go-to-market & commercial model
Design customer priorities, channels, coverage, interfaces, capabilities and governance around the chosen opportunity.
Organization & change
Align leaders, decision rights, resources and first-wave behaviors so the market entry moves from recommendation to execution.
03 / WHEN WE HELP
Built for the moments when the entry decision carries real consequence.
You are evaluating Mexico from outside the market.
The opportunity looks attractive, but the organization needs a grounded thesis before committing capital, partners or executive attention.
A launch or asset expansion is approaching.
Access, stakeholder, evidence and commercial assumptions must converge into one credible entry roadmap.
A partner or channel decision is at stake.
You need to know what to retain, what to delegate and which partner can truly activate the opportunity.
The current business is not delivering its potential.
The issue may sit in positioning, access, channels, capabilities, governance—or in the original market thesis itself.
04 / OUR APPROACH
Local depth. Executive choices. Activation built in.
Frame
Define the strategic decision, ambition, investment boundary and evidence required to move.
Decode
Integrate market, access, stakeholder, competitor and organizational realities into a decision-grade view.
Choose
Make explicit choices about priority opportunities, entry model, value logic and route to market.
Design
Build the business case, operating model, capability agenda and sequenced market-entry roadmap.
Mobilize
Align leaders, partners and teams around ownership, governance and measurable first moves.
The scope can be shaped as a focused decision sprint or a staged market-entry engagement.
05 / DECISION-GRADE OUTPUTS
A decision system—not a market report.
Every engagement is built around the decision at hand. Typical outputs include:
- 01Mexico market-entry thesis and strategic choices
- 02Opportunity, portfolio and segment prioritization
- 03Access, stakeholder and value pathway
- 04Entry-model and partner assessment
- 05Business case, scenarios and decision risks
- 06Go-to-market and operating-model blueprint
- 07Sequenced activation and change roadmap
07 / WHY ACCESSLERATE
Mexico strategy shaped by someone who has operated inside the market.
Accesslerate combines external objectivity with the judgment of a healthcare operator. Yuriko Tovar brings more than 20 years leading growth, market access, commercial operations, patient solutions and transformation across Mexico and Latin America. She remains directly involved from the first question to the activation roadmap.
20+Years across healthcare
7Global healthcare companies
5Healthcare sectors
Operator experience spans Pharma, Biotech, Consumer Health, MedTech and Diagnostics.
08 / FREQUENTLY ASKED QUESTIONS
What healthcare leaders ask before entering Mexico.
01What does a healthcare market-entry engagement include?+
The scope can include market attractiveness, opportunity and portfolio prioritization, access and stakeholder pathways, entry-model scenarios, partner assessment, business case, go-to-market design, organizational readiness and an activation roadmap.
02Do you recommend direct entry or a local partner?+
There is no universal answer. We compare models against the opportunity, desired control, economics, speed, regulatory and access requirements, internal capabilities and the role a partner must play beyond distribution.
03How early should Market Access be included?+
From the beginning. Access, evidence, value, affordability and stakeholder adoption shape the real addressable opportunity and should inform the entry thesis—not be added after the commercial plan.
04Which healthcare sectors do you support?+
Accesslerate works across Pharma, Biotech, Consumer Health, MedTech, Diagnostics, Health Services and investor-backed healthcare opportunities.
05Can this work connect Mexico with a Latin America strategy?+
Yes. We can build a Mexico-specific entry thesis, compare markets across Latin America or use Mexico as part of a regional sequencing and portfolio decision.
06How does an engagement begin?+
We start by framing the decision, existing assumptions, available evidence, stakeholders and investment boundary. The work can then take shape as a focused sprint or a staged engagement through activation.
09 / START A CONVERSATION
Bring us the Mexico question that must be right before resources move.
In a focused 30-minute conversation, we will explore the opportunity, the decisions at stake and whether Accesslerate is the right partner for your market-entry agenda.